The clinical significance of drug craving.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 1, doi. 10.1111/j.1749-6632.2011.06298.x
- By:
- Publication type:
- Article
Works matching IS 00778923 AND DT 2012 AND VI 1248 AND IP 1
Results: 7
1
2
Designer drugs: a medicinal chemistry perspective.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 18, doi. 10.1111/j.1749-6632.2011.06199.x
- By:
- Publication type:
- Article
3
Mouse models for studying genetic influences on factors determining smoking cessation success in humans.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 39, doi. 10.1111/j.1749-6632.2011.06415.x
- By:
- Publication type:
- Article
4
The history of the development of buprenorphine as an addiction therapeutic.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 124, doi. 10.1111/j.1749-6632.2011.06352.x
- By:
- Publication type:
- Article
5
Socioeconomic status and smoking: a review.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 107, doi. 10.1111/j.1749-6632.2011.06202.x
- By:
- Publication type:
- Article
6
Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 71, doi. 10.1111/j.1749-6632.2011.06299.x
- By:
- Publication type:
- Article
7
A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1248, n. 1, p. 89, doi. 10.1111/j.1749-6632.2011.06261.x
- By:
- Publication type:
- Article